Description

DOXOSIGN 400 TAB is a powerful bronchodilator containing Doxofylline 400 mg, a xanthine derivative that helps ease breathing in individuals with asthma, chronic obstructive pulmonary disease (COPD), and bronchitis. Unlike theophylline, Doxofylline has minimal cardiac and gastrointestinal side effects, making it a safer long-term therapy option.

It works by relaxing bronchial smooth muscles, improving airflow, and reducing resistance in the respiratory tract.

Therapeutic Uses:

• Bronchial asthma

• Chronic obstructive pulmonary disease (COPD)

• Acute and chronic bronchitis

• Allergic bronchospasm

• Adjunct to inhalation therapy in maintenance of lung function

Key Benefits:

• Relieves bronchospasm and improves breathing

• Lower risk of side effects compared to theophylline

• Longer duration of action for improved compliance

• Safe for use in adults and elderly patients

• Can be used in monotherapy or combination therapy

DOXOSIGN 400 TAB is manufactured under strict WHO-GMP and ISO-certified conditions and exported internationally by BLUEPILL EXPRESS, a leading pharmaceutical supplier. The company ensures global distribution across Asia, Africa, Europe, the Middle East, and Latin America, with regulatory support and reliable delivery services.